{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:14:12Z","timestamp":1793297652163,"version":"4.5.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02598-4","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T06:26:20Z","timestamp":1773037580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Nature-inspired confined cascade enzyme nanoreactors for targeted atherosclerosis therapy"],"prefix":"10.1038","volume":"11","author":[{"given":"Yuehuang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6454-2333","authenticated-orcid":false,"given":"Hongping","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"2598_CR1","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41569-021-00668-4","volume":"19","author":"SE Engelen","year":"2022","unstructured":"Engelen, S. E. et al. Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?. Nat. Rev. Cardiol. 19, 522\u2013542 (2022).","journal-title":"Nat. Rev. Cardiol."},{"key":"2598_CR2","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","volume":"185","author":"JLM Bj\u00f6rkegren","year":"2022","unstructured":"Bj\u00f6rkegren, J. L. M. & Lusis, A. J. Atherosclerosis: recent developments. Cell 185, 1630\u20131645 (2022).","journal-title":"Cell"},{"key":"2598_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1161\/CIRCRESAHA.121.319822","volume":"130","author":"AC Doran","year":"2022","unstructured":"Doran, A. C. Inflammation resolution: implications for atherosclerosis. Circ. Res. 130, 130\u2013148 (2022).","journal-title":"Circ. Res."},{"key":"2598_CR4","doi-asserted-by":"publisher","first-page":"3808","DOI":"10.1021\/acsnano.1c08391","volume":"16","author":"ZY Wu","year":"2022","unstructured":"Wu, Z. Y. et al. Carrier-free trehalose-based nanomotors targeting macrophages in inflammatory plaque for treatment of atherosclerosis. ACS Nano 16, 3808\u20133820 (2022).","journal-title":"ACS Nano"},{"key":"2598_CR5","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.apsb.2022.04.002","volume":"13","author":"XY Liang","year":"2023","unstructured":"Liang, X. Y. et al. Highly sensitive H2O2-scavenging nanobionic system for precise treatment of atherosclerosis. Acta Pharm. Sin. B 13, 372\u2013389 (2023).","journal-title":"Acta Pharm. Sin. B"},{"key":"2598_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202300439","volume":"35","author":"H Xu","year":"2023","unstructured":"Xu, H. et al. Duplex responsive nanoplatform with cascade targeting for atherosclerosis photoacoustic diagnosis and multichannel combination therapy. Adv. Mater. 35, e2300439 (2023).","journal-title":"Adv. Mater."},{"key":"2598_CR7","doi-asserted-by":"publisher","first-page":"120677","DOI":"10.1016\/j.biomaterials.2021.120677","volume":"269","author":"LM Pham","year":"2021","unstructured":"Pham, L. M. et al. Targeting and clearance of senescent foamy macrophages and senescent endothelial cells by antibody-functionalized mesoporous silica nanoparticles for alleviating aorta atherosclerosis. Biomaterials 269, 120677 (2021).","journal-title":"Biomaterials"},{"key":"2598_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34248-y","volume":"13","author":"XX Fu","year":"2022","unstructured":"Fu, X. X. et al. Small molecule-assisted assembly of multifunctional ceria nanozymes for synergistic treatment of atherosclerosis. Nat. Commun. 13, 6528 (2022).","journal-title":"Nat. Commun."},{"key":"2598_CR9","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.7150\/thno.87484","volume":"13","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. Targeted elimination of senescent cells by engineered extracellular vesicles attenuates atherosclerosis in ApoE(\u2212\/\u2212) mice with minimal side effects. Theranostics 13, 5114\u20135129 (2023).","journal-title":"Theranostics"},{"key":"2598_CR10","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/ng1295-376","volume":"11","author":"YB Li","year":"1995","unstructured":"Li, Y. B. et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet. 11, 376\u2013381 (1995).","journal-title":"Nat. Genet."},{"key":"2598_CR11","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1161\/01.CIR.97.19.1930","volume":"97","author":"D Lapenna","year":"1998","unstructured":"Lapenna, D. et al. Glutathione-related antioxidant defenses in human atherosclerotic plaques. Circulation 97, 1930\u20131934 (1998).","journal-title":"Circulation"},{"key":"2598_CR12","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/eurheartj\/ehm500","volume":"29","author":"H Fujimoto","year":"2008","unstructured":"Fujimoto, H. et al. Manganese superoxide dismutase polymorphism affects the oxidized low-density lipoprotein-induced apoptosis of macrophages and coronary artery disease. Eur. Heart J. 29, 1267\u20131274 (2008).","journal-title":"Eur. Heart J."},{"key":"2598_CR13","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1021\/acs.accounts.9b00140","volume":"52","author":"MM Liang","year":"2019","unstructured":"Liang, M. M. & Yan, X. Y. Nanozymes: from new concepts, mechanisms, and standards to applications. Acc. Chem. Res. 52, 2190\u20132200 (2019).","journal-title":"Acc. Chem. Res."},{"key":"2598_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202110432","volume":"32","author":"YJ Ai","year":"2021","unstructured":"Ai, Y. J. et al. Recent advances in nanozymes: from matters to bioapplications. Adv. Funct. Mater. 32, e2110432 (2021).","journal-title":"Adv. Funct. Mater."},{"key":"2598_CR15","doi-asserted-by":"publisher","first-page":"121495","DOI":"10.1016\/j.biomaterials.2022.121495","volume":"284","author":"FC Nan","year":"2022","unstructured":"Nan, F. C. et al. Iron phthalocyanine-derived nanozyme as dual reactive oxygen species generation accelerator for photothermally enhanced tumor catalytic therapy. Biomaterials 284, 121495 (2022).","journal-title":"Biomaterials"},{"key":"2598_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202211210","volume":"36","author":"JY Sheng","year":"2024","unstructured":"Sheng, J. Y. et al. Multienzyme-like nanozymes: regulation, rational design, and application. Adv. Mater. 36, e2211210 (2024).","journal-title":"Adv. Mater."},{"key":"2598_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12951-021-00771-1","volume":"19","author":"N Alizadeh","year":"2021","unstructured":"Alizadeh, N. & Salimi, A. Multienzymes activity of metals and metal oxide nanomaterials: applications from biotechnology to medicine and environmental engineering. J. Nanobiotechnol. 19, 26 (2021).","journal-title":"J. Nanobiotechnol."},{"key":"2598_CR18","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1039\/C8CS00457A","volume":"48","author":"JJ Wu","year":"2019","unstructured":"Wu, J. J. et al. Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II). Chem. Soc. Rev. 48, 1004\u20131076 (2019).","journal-title":"Chem. Soc. Rev."},{"key":"2598_CR19","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jconrel.2022.10.007","volume":"351","author":"YH Wang","year":"2022","unstructured":"Wang, Y. H. et al. Advancements of Prussian blue-based nanoplatforms in biomedical fields: progress and perspectives. J. Control. Release 351, 752\u2013778 (2022).","journal-title":"J. Control. Release"},{"key":"2598_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300354","volume":"10","author":"XD He","year":"2023","unstructured":"He, X. D. et al. Bimodal antimicrobial surfaces of phytic acid\u2014Prussian blue nanoparticles\u2014cationic polymer networks. Adv. Sci. 10, e2300354 (2023).","journal-title":"Adv. Sci."},{"key":"2598_CR21","doi-asserted-by":"publisher","first-page":"121980","DOI":"10.1016\/j.biomaterials.2022.121980","volume":"293","author":"BW Zhang","year":"2023","unstructured":"Zhang, B. W. et al. Biomimetic Prussian blue nanozymes with enhanced bone marrow-targeting for treatment of radiation-induced hematopoietic injury. Biomaterials 293, 121980 (2023).","journal-title":"Biomaterials"},{"key":"2598_CR22","doi-asserted-by":"publisher","first-page":"4561","DOI":"10.1021\/acsnano.4c14445","volume":"19","author":"MM Long","year":"2025","unstructured":"Long, M. M. et al. Prussian blue nanozyme featuring enhanced superoxide dismutase-like activity for myocardial ischemia\u2012reperfusion injury treatment. ACS Nano 19, 4561\u20134581 (2025).","journal-title":"ACS Nano"},{"key":"2598_CR23","doi-asserted-by":"publisher","first-page":"57382","DOI":"10.1021\/acsami.0c18357","volume":"12","author":"ZG Qin","year":"2020","unstructured":"Qin, Z. G. et al. Achieving ultrasmall Prussian blue nanoparticles as high-performance biomedical agents with multifunctions. ACS Appl. Mater. Interfaces 12, 57382\u201357390 (2020).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2598_CR24","doi-asserted-by":"publisher","first-page":"11697","DOI":"10.1021\/acs.nanolett.4c03314","volume":"24","author":"ZG Qin","year":"2024","unstructured":"Qin, Z. G. et al. Ultrasmall Prussian blue nanozyme attenuates osteoarthritis by scavenging reactive oxygen species and regulating macrophage phenotype. Nano Lett 24, 11697\u201311705 (2024).","journal-title":"Nano Lett"},{"key":"2598_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201800347","volume":"7","author":"ZG Qin","year":"2018","unstructured":"Qin, Z. G., Li, Y. & Gu, N. Progress in applications of Prussian blue nanoparticles in biomedicine. Adv. Healthc. Mater. 7, e1800347 (2018).","journal-title":"Adv. Healthc. Mater."},{"key":"2598_CR26","doi-asserted-by":"publisher","first-page":"5860","DOI":"10.1021\/jacs.5b12070","volume":"138","author":"W Zhang","year":"2016","unstructured":"Zhang, W. et al. Prussian Blue nanoparticles as multienzyme mimetics and reactive oxygen species scavengers. J. Am. Chem. Soc. 138, 5860\u20135865 (2016).","journal-title":"J. Am. Chem. Soc."},{"key":"2598_CR27","doi-asserted-by":"publisher","first-page":"5272","DOI":"10.1039\/D2TB02617A","volume":"11","author":"K Lu","year":"2023","unstructured":"Lu, K. et al. Progress in the preparation of Prussian blue-based nanomaterials for biomedical applications. J. Mater. Chem. B 11, 5272\u20135300 (2023).","journal-title":"J. Mater. Chem. B"},{"key":"2598_CR28","first-page":"6104","volume":"13","author":"YY Li","year":"2021","unstructured":"Li, Y. Y. et al. Ultrasmall Prussian blue nanoparticles attenuate UVA-induced cellular senescence in human dermal fibroblasts by inhibiting the ERK\/AP-1 pathway. Nanoscale 13, 6104\u201316112 (2021).","journal-title":"Nanoscale"},{"key":"2598_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202108167","volume":"34","author":"ZY Wei","year":"2022","unstructured":"Wei, Z. Y. et al. Selenopeptide nanomedicine activates natural killer cells for enhanced tumor chemoimmunotherapy. Adv. Mater. 34, e2108167 (2022).","journal-title":"Adv. Mater."},{"key":"2598_CR30","doi-asserted-by":"publisher","first-page":"2000420","DOI":"10.1002\/advs.202000420","volume":"7","author":"ZT Rosenkrans","year":"2020","unstructured":"Rosenkrans, Z. T. et al. Selenium-doped carbon quantum dots act as broad-spectrum antioxidants for acute kidney injury management. Adv. Sci. 7, 2000420 (2020).","journal-title":"Adv. Sci."},{"key":"2598_CR31","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.biopha.2018.12.146","volume":"111","author":"A Khurana","year":"2019","unstructured":"Khurana, A. et al. Therapeutic applications of selenium nanoparticles. Biomed. Pharmacother. 111, 802\u2013812 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"2598_CR32","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1089\/ars.2010.3586","volume":"15","author":"E Lubos","year":"2011","unstructured":"Lubos, E., Loscalzo, J. & Handy, D. E. Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 15, 1957\u20131997 (2011).","journal-title":"Antioxid. Redox Signal."},{"key":"2598_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/bit.25136","volume":"111","author":"F Jia","year":"2014","unstructured":"Jia, F., Narasimhan, B. & Mallapragada, S. Materials-based strategies for multienzyme immobilization and colocalization: a review. Biotechnol. Bioeng. 111, 209\u2013222 (2014).","journal-title":"Biotechnol. Bioeng."},{"key":"2598_CR34","doi-asserted-by":"publisher","first-page":"7664","DOI":"10.1021\/bi9700429","volume":"36","author":"S Rhee","year":"1997","unstructured":"Rhee, S. et al. Crystal structures of a mutant (betaK87T) tryptophan synthase alpha2beta2 complex with ligands bound to the active sites of the alpha- and beta-subunits reveal ligand-induced conformational changes. Biochemistry 36, 7664\u20137680 (1997).","journal-title":"Biochemistry"},{"key":"2598_CR35","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.cej.2022.140276","volume":"454","author":"H Yuan","year":"2023","unstructured":"Yuan, H. et al. Biomimetic multienzyme nanocomplex for efficient cascade reactions. Chem. Eng. J. 454, 1385\u20138947 (2023).","journal-title":"Chem. Eng. J."},{"key":"2598_CR36","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nnano.2016.54","volume":"11","author":"A Kuchler","year":"2016","unstructured":"Kuchler, A. et al. Enzymatic reactions in confined environments. Nat. Nanotechnol. 11, 409\u2013420 (2016).","journal-title":"Nat. Nanotechnol."},{"key":"2598_CR37","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41929-018-0117-2","volume":"1","author":"WH Chen","year":"2018","unstructured":"Chen, W. H. et al. Biocatalytic cascades driven by enzymes encapsulated in metal\u2013organic framework nanoparticles. Nat. Catal. 1, 689\u2013695 (2018).","journal-title":"Nat. Catal."},{"key":"2598_CR38","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1021\/acs.accounts.0c00280","volume":"53","author":"YN Yang","year":"2020","unstructured":"Yang, Y. N. et al. Silica-based nanoparticles for biomedical applications: from nanocarriers to biomodulators. Acc. Chem. Res. 53, 1545\u20131556 (2020).","journal-title":"Acc. Chem. Res."},{"key":"2598_CR39","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1021\/acsbiomaterials.2c00629","volume":"8","author":"CY Song","year":"2022","unstructured":"Song, C. Y. et al. Confined construction of ultrasmall molybdenum disulfide-loaded porous silica particles for efficient tumor therapy. ACS Biomater. Sci. Eng. 8, 3377\u20133386 (2022).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"2598_CR40","doi-asserted-by":"publisher","first-page":"5785","DOI":"10.1039\/c2an36237f","volume":"137","author":"XD Cao","year":"2012","unstructured":"Cao, X. D. et al. Catalytic activity and stability of glucose oxidase\/horseradish peroxidase coconfined in macroporous silica foam. Analyst 137, 5785\u20135791 (2012).","journal-title":"Analyst"},{"key":"2598_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202405252","volume":"63","author":"JY Feng","year":"2024","unstructured":"Feng, J. Y. et al. Micelles cascade assembly to tandem porous catalyst for waste plastics upcycling. Angew. Chem. Int. Ed. Engl. 63, e202405252 (2024).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"2598_CR42","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jcis.2022.12.151","volume":"635","author":"W Xiao","year":"2023","unstructured":"Xiao, W. et al. IrO2 clusters loaded on dendritic mesoporous silica nanospheres with superior peroxidase-like activity for sensitive detection of acetylcholinesterase and its inhibitors. J.Colloid Interf. Sci. 635, 481\u2013493 (2023).","journal-title":"J.Colloid Interf. Sci."},{"key":"2598_CR43","first-page":"2468","volume":"519","author":"QL Liu","year":"2022","unstructured":"Liu, Q. L. et al. Dendritic mesoporous silica nanosphere supported highly dispersed Pd-CoOx catalysts for catalytic oxidation of toluene. Mol. Catal. 519, 2468\u20138231 (2022).","journal-title":"Mol. Catal."},{"key":"2598_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00424-8","volume":"8","author":"MF Huo","year":"2017","unstructured":"Huo, M. F. et al. Tumor-selective catalytic nanomedicine by nanocatalyst delivery. Nat. Commun. 8, 357 (2017).","journal-title":"Nat. Commun."},{"key":"2598_CR45","first-page":"2468","volume":"26","author":"S Malekmohammadi","year":"2022","unstructured":"Malekmohammadi, S. et al. Nonordered dendritic mesoporous silica nanoparticles as promising platforms for advanced methods of diagnosis and therapies. Mater. Today Chem. 26, 2468\u20135194 (2022).","journal-title":"Mater. Today Chem."},{"key":"2598_CR46","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.cej.2022.140067","volume":"454","author":"H Fang","year":"2023","unstructured":"Fang, H. et al. Dual-responsive targeted atherosclerosis therapy through a multieffective nanoplatform with anti-inflammatory, lipid-regulating and autophagy. Chem. Eng. J. 454, 1385\u20138947 (2023).","journal-title":"Chem. Eng. J."},{"key":"2598_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16439-7","volume":"11","author":"C Gao","year":"2020","unstructured":"Gao, C. et al. Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines. Nat. Commun. 11, 2622 (2020).","journal-title":"Nat. Commun."},{"key":"2598_CR48","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1021\/acsnano.0c07973","volume":"15","author":"LS Feng","year":"2021","unstructured":"Feng, L. S. et al. Neutrophil-like cell-membrane-coated nanozyme therapy for ischemic brain damage and long-term neurological functional recovery. ACS Nano 15, 2263\u20132280 (2021).","journal-title":"ACS Nano"},{"key":"2598_CR49","doi-asserted-by":"publisher","first-page":"20377","DOI":"10.1021\/acsnano.1c08689","volume":"15","author":"TT Xiao","year":"2021","unstructured":"Xiao, T. T. et al. Macrophage membrane-camouflaged responsive polymer nanogels enable magnetic resonance imaging-guided chemotherapy\/chemodynamic therapy of orthotopic glioma. ACS Nano 15, 20377\u201320390 (2021).","journal-title":"ACS Nano"},{"key":"2598_CR50","doi-asserted-by":"publisher","first-page":"9845459","DOI":"10.34133\/2022\/9845459","volume":"2022","author":"L Chen","year":"2022","unstructured":"Chen, L. et al. Platelet membrane-coated nanocarriers targeting plaques to deliver anti-CD47 antibody for atherosclerotic therapy. Research 2022, 9845459 (2022).","journal-title":"Research"},{"key":"2598_CR51","doi-asserted-by":"publisher","first-page":"10755","DOI":"10.1016\/j.colsurfb.2019.110755","volume":"188","author":"KY Wang","year":"2020","unstructured":"Wang, K. Y. et al. Neutrophil membranes coated, antibiotic agent loaded nanoparticles targeting to the lung inflammation. Colloid Surf. B 188, 10755 (2020).","journal-title":"Colloid Surf. B"},{"key":"2598_CR52","doi-asserted-by":"publisher","first-page":"40292","DOI":"10.1021\/acsami.3c08573","volume":"15","author":"CG Ding","year":"2023","unstructured":"Ding, C. G. et al. Neutrophil membrane-inspired nanorobots act as antioxidants ameliorate ischemia\u2012reperfusion-induced acute kidney injury. ACS Appl. Mater. Interfaces 15, 40292\u201340303 (2023).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2598_CR53","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1038\/s41565-018-0254-4","volume":"13","author":"QZ Zhang","year":"2018","unstructured":"Zhang, Q. Z. et al. Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis. Nat. Nanotechnol. 13, 1182\u20131190 (2018).","journal-title":"Nat. Nanotechnol."},{"key":"2598_CR54","first-page":"369","volume":"23","author":"DJ Han","year":"2023","unstructured":"Han, D. J. et al. Neutrophil membrane-camouflaged nanoparticles alleviate inflammation and promote angiogenesis in ischemic myocardial injury. Bioact. Mater. 23, 369\u2013382 (2023).","journal-title":"Bioact. Mater."},{"key":"2598_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202315275","volume":"34","author":"JY Song","year":"2024","unstructured":"Song, J. Y. et al. Neutrophil hitchhiking biomimetic nanozymes prime neuroprotective effects of ischemic stroke in a tailored \u201cburning the bridges\u201d manner. Adv. Funct. Mater. 34, e2315275 (2024).","journal-title":"Adv. Funct. Mater."},{"key":"2598_CR56","doi-asserted-by":"publisher","first-page":"7721","DOI":"10.1021\/acsnano.3c00288","volume":"17","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Neutrophil-membrane-coated biomineralized metal-organic framework nanoparticles for atherosclerosis treatment by targeting gene silencing. ACS Nano 17, 7721\u20137732 (2023).","journal-title":"ACS Nano"},{"key":"2598_CR57","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","volume":"19","author":"A Herrero-Cervera","year":"2022","unstructured":"Herrero-Cervera, A., Soehnlein, O. & Kenne, E. Neutrophils in chronic inflammatory diseases. Cell. Mol. Immunol. 19, 177\u2013191 (2022).","journal-title":"Cell. Mol. Immunol."},{"key":"2598_CR58","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.apsb.2018.12.009","volume":"9","author":"X Cao","year":"2019","unstructured":"Cao, X. et al. Neutrophil-mimicking therapeutic nanoparticles for targeted chemotherapy of pancreatic carcinoma. Acta Pharm. Sin. B 9, 575\u2013589 (2019).","journal-title":"Acta Pharm. Sin. B"},{"key":"2598_CR59","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1093\/eurheartj\/ehx244","volume":"38","author":"DS Gaul","year":"2017","unstructured":"Gaul, D. S., Stein, S. & Matter, C. M. Neutrophils in cardiovascular disease. Eur. Heart J. 38, 1702\u20131704 (2017).","journal-title":"Eur. Heart J."},{"key":"2598_CR60","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1021\/bm300248u","volume":"13","author":"C Freese","year":"2012","unstructured":"Freese, C. et al. Size- and coating-dependent uptake of polymer-coated gold nanoparticles in primary human dermal microvascular endothelial cells. Biomacromolecules 13, 1533\u20131543 (2012).","journal-title":"Biomacromolecules"},{"key":"2598_CR61","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12951-015-0075-7","volume":"13","author":"M Shilo","year":"2015","unstructured":"Shilo, M. et al. The effect of nanoparticle size on the probability to cross the blood\u2012brain barrier: an in vitro endothelial cell model. J. Nanobiotechnol. 13, 19 (2015).","journal-title":"J. Nanobiotechnol."},{"key":"2598_CR62","doi-asserted-by":"publisher","first-page":"20825","DOI":"10.1021\/acsnano.3c05853","volume":"17","author":"MZ Xu","year":"2023","unstructured":"Xu, M. Z. et al. Size-dependent in vivo transport of nanoparticles: implications for delivery, targeting, and clearance. ACS Nano 17, 20825\u201320849 (2023).","journal-title":"ACS Nano"},{"key":"2598_CR63","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1126\/science.6828875","volume":"220","author":"RM Hochmuth","year":"1983","unstructured":"Hochmuth, R. M., Evans, C. A., Wiles, H. C. & McCown, J. T. Mechanical measurement of red cell membrane thickness. Science 220, 101\u2013102 (1983).","journal-title":"Science"},{"key":"2598_CR64","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/adma.201405105","volume":"27","author":"Y Tao","year":"2015","unstructured":"Tao, Y. et al. Bifunctionalized mesoporous silica-supported gold nanoparticles: intrinsic oxidase and peroxidase catalytic activities for antibacterial applications. Adv. Mater. 27, 1097\u20131104 (2015).","journal-title":"Adv. Mater."},{"key":"2598_CR65","doi-asserted-by":"publisher","first-page":"16934","DOI":"10.1021\/acsnano.4c03069","volume":"18","author":"Q Shen","year":"2024","unstructured":"Shen, Q. et al. Biodegradable mesoporous organosilica-based nanostabilizer targeting mast cells for long-term treatment of allergic diseases. ACS Nano 18, 16934\u201316946 (2024).","journal-title":"ACS Nano"},{"key":"2598_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14043-y","volume":"1","author":"I Gomez","year":"2020","unstructured":"Gomez, I. et al. Neutrophil microvesicles drive atherosclerosis by delivering miR-155 to atheroprone endothelium. Nat. Commun. 1, 214 (2020).","journal-title":"Nat. Commun."},{"key":"2598_CR67","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ijpharm.2018.10.056","volume":"553","author":"WX Xu","year":"2018","unstructured":"Xu, W. X. et al. Dendrimer-like mesoporous silica nanospheres with suitable surface functionality to combat the multidrug resistance. Int. J. Pharm. 553, 349\u2013362 (2018).","journal-title":"Int. J. Pharm."},{"key":"2598_CR68","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1021\/nn100690m","volume":"4","author":"H Meng","year":"2010","unstructured":"Meng, H. et al. Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line. ACS Nano 4, 4539\u20134550 (2010).","journal-title":"ACS Nano"},{"key":"2598_CR69","first-page":"2468","volume":"26","author":"ZZ Jiang","year":"2022","unstructured":"Jiang, Z. Z. et al. Neutrophil membrane camouflaged nanoprobes for NIR-II fluorescence imaging of inflamed, high-risk atherosclerotic plaques in mouse and rabbit models. Mater. Today Chem. 26, 2468\u20135194 (2022).","journal-title":"Mater. Today Chem."},{"key":"2598_CR70","doi-asserted-by":"publisher","first-page":"5176","DOI":"10.1021\/acsanm.1c00617","volume":"4","author":"KZ Feng","year":"2021","unstructured":"Feng, K. Z. et al. Prussian blue nanoparticles having various sizes and crystallinities for multienzyme catalysis and magnetic resonance imaging. ACS Appl. Nano Mater. 4, 5176\u20135186 (2021).","journal-title":"ACS Appl. Nano Mater."},{"key":"2598_CR71","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","volume":"118","author":"MA Gimbrone Jr.","year":"2016","unstructured":"Gimbrone, M. A. Jr. & Garc\u00eda-Carde\u00f1a, G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ. Res. 118, 620\u2013636 (2016).","journal-title":"Circ. Res."},{"key":"2598_CR72","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202304465","volume":"62","author":"WL Liu","year":"2023","unstructured":"Liu, W. L. et al. Integrated cascade nanozymes with antisenescence activities for atherosclerosis therapy. Angew. Chem. Int. Ed. Engl. 62, e202304465 (2023).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"2598_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072063","volume":"8","author":"F Cheng","year":"2013","unstructured":"Cheng, F. et al. Impact of glutathione peroxidase-1 deficiency on macrophage foam cell formation and proliferation: implications for atherogenesis. PLoS ONE 8, e72063 (2013).","journal-title":"PLoS ONE"},{"key":"2598_CR74","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1161\/CIRCRESAHA.118.312563","volume":"123","author":"AJ Donato","year":"2018","unstructured":"Donato, A. J., Machin, D. R. & Lesniewski, L. A. Mechanisms of dysfunction in the aging vasculature and role in age-related disease. Circ. Res. 123, 825\u2013848 (2018).","journal-title":"Circ. Res."},{"key":"2598_CR75","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12990","volume":"18","author":"ZS Chang","year":"2019","unstructured":"Chang, Z. S. et al. Forkhead box O3 protects the heart against paraquat-induced aging-associated phenotypes by upregulating the expression of antioxidant enzymes. Aging Cell 18, e12990 (2019).","journal-title":"Aging Cell"},{"key":"2598_CR76","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.1039\/C8NR09397K","volume":"11","author":"N Singh","year":"2019","unstructured":"Singh, N. et al. A manganese oxide nanozyme prevents the oxidative damage of biomolecules without affecting the endogenous antioxidant system. Nanoscale 11, 3855\u20133863 (2019).","journal-title":"Nanoscale"},{"key":"2598_CR77","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202302485","volume":"13","author":"BJ Zhu","year":"2023","unstructured":"Zhu, B. J. et al. A glutathione peroxidase-mimicking nanozyme precisely alleviates reactive oxygen species and promotes periodontal bone regeneration. Adv. Healthc. Mater. 13, e2302485 (2023).","journal-title":"Adv. Healthc. Mater."},{"key":"2598_CR78","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1161\/CIRCULATIONAHA.117.029550","volume":"136","author":"T El-Sayed","year":"2017","unstructured":"El-Sayed, T. et al. Radiation-induced DNA damage in operators performing endovascular aortic repair. Circulation 136, 2406\u20132416 (2017).","journal-title":"Circulation"},{"key":"2598_CR79","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.nantod.2021.101351","volume":"42","author":"H Yang","year":"2022","unstructured":"Yang, H. et al. Atherosclerotic plaque-targeted nanotherapeutics ameliorates atherogenesis by blocking macrophage-driven inflammation. Nano Today 42, 1748\u20130132 (2022).","journal-title":"Nano Today"},{"key":"2598_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202404463","volume":"20","author":"P Wei","year":"2024","unstructured":"Wei, P. et al. Gene-engineered cerium-exosomes mediate atherosclerosis therapy through remodeling of the inflammatory microenvironment and DNA damage repair. Small 20, e2404463 (2024).","journal-title":"Small"},{"key":"2598_CR81","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41586-024-07693-6","volume":"634","author":"JR Lavillegrand","year":"2024","unstructured":"Lavillegrand, J. R. et al. Alternating high-fat diet enhances atherosclerosis by neutrophil reprogramming. Nature 634, 447\u2013456 (2024).","journal-title":"Nature"},{"key":"2598_CR82","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1161\/01.CIR.0000143174.41810.10","volume":"110","author":"Y Fukumoto","year":"2004","unstructured":"Fukumoto, Y. et al. Genetically determined resistance to collagenase action augments interstitial collagen accumulation in atherosclerotic plaques. Circulation 110, 1953\u20131959 (2004).","journal-title":"Circulation"},{"key":"2598_CR83","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","volume":"401","author":"PM Ridker","year":"2023","unstructured":"Ridker, P. M. et al. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomized trials. Lancet 401, 1293\u20131301 (2023).","journal-title":"Lancet"},{"key":"2598_CR84","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1172\/JCI121985","volume":"129","author":"S Lucotti","year":"2019","unstructured":"Lucotti, S. et al. Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1\/thromboxane A2. J. Clin. Investig. 129, 1845\u20131862 (2019).","journal-title":"J. Clin. Investig."},{"key":"2598_CR85","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1056\/NEJMoa1809798","volume":"380","author":"PM Ridker","year":"2019","unstructured":"Ridker, P. M. et al. Low-dose methotrexate for the prevention of atherosclerotic events. N. Engl. J. Med. 380, 752\u2013762 (2019).","journal-title":"N. Engl. J. Med."},{"key":"2598_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113683","volume":"382","author":"PY Wen","year":"2025","unstructured":"Wen, P. Y. et al. Engineering durable antioxidative nanoreactors as synthetic organelles for autoregulatory cellular protection against oxidative stress. J. Control. Release 382, 113683 (2025).","journal-title":"J. Control. Release"},{"key":"2598_CR87","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","volume":"20","author":"HJ Forman","year":"2021","unstructured":"Forman, H. J. & Zhang, H. Q. Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat. Rev. Drug Discov. 20, 689\u2013709 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2598_CR88","doi-asserted-by":"publisher","first-page":"123622","DOI":"10.1016\/j.biomaterials.2025.123622","volume":"325","author":"H Ding","year":"2026","unstructured":"Ding, H. et al. Subcellular distribution of Prussian blue nanozymes dictates enzymatic activity and macrophage polarization for effective colitis therapy. Biomaterials 325, 123622 (2026).","journal-title":"Biomaterials"},{"key":"2598_CR89","doi-asserted-by":"publisher","first-page":"2421512","DOI":"10.1002\/adfm.202421512","volume":"35","author":"CL Song","year":"2025","unstructured":"Song, C. L., Ling, H., Yang, G. Q. & Ding, J. X. Microenvironments-targeted nanomaterials for atherosclerosis therapy. Adv. Funct. Mater. 35, 2421512 (2025).","journal-title":"Adv. Funct. Mater."},{"key":"2598_CR90","doi-asserted-by":"publisher","first-page":"123460","DOI":"10.1016\/j.watres.2025.123460","volume":"280","author":"H Lee","year":"2025","unstructured":"Lee, H., Fu, H. & Gray, K. A. Making waves: pioneering a nanoconfinement platform with mesoporous silica for sustainable water management and environmental applications. Water Res. 280, 123460 (2025).","journal-title":"Water Res."},{"key":"2598_CR91","doi-asserted-by":"publisher","first-page":"124555","DOI":"10.1016\/j.seppur.2023.124555","volume":"324","author":"MQ Li","year":"2023","unstructured":"Li, M. Q., Huang, X. S., Zhang, G. D., Tang, Z. C. & Hu, D. C. Elaborating the improving SO2 resistance mechanism of CeWTi catalysts through framework confined ordered mesoporous structures for low-temperature NH3-SCR reaction. Sep. Purif. Technol. 324, 124555 (2023).","journal-title":"Sep. Purif. Technol."},{"key":"2598_CR92","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.mattod.2020.12.005","volume":"44","author":"XL Cai","year":"2021","unstructured":"Cai, X. L. et al. Nanozyme-involved biomimetic cascade catalysis for biomedical applications. Mater. Today 44, 211\u2013228 (2021).","journal-title":"Mater. Today"},{"key":"2598_CR93","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41392-024-01859-4","volume":"9","author":"Y Yang","year":"2024","unstructured":"Yang, Y. et al. Genetically programmable cell membrane-camouflaged nanoparticles for targeted combination therapy of colorectal cancer. Signal. Transduct. Target. Ther. 9, 158 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"2598_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114895","volume":"198","author":"PY Wen","year":"2023","unstructured":"Wen, P. Y. et al. Stealth and pseudostealth nanocarriers. Adv. Drug Deliv. Rev. 198, 114895 (2023).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2598_CR95","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1021\/acsnano.6b06477","volume":"11","author":"T Kang","year":"2017","unstructured":"Kang, T. et al. Nanoparticles coated with neutrophil membranes can effectively treat cancer metastasis. ACS Nano 11, 1397\u20131411 (2017).","journal-title":"ACS Nano"},{"key":"2598_CR96","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1021\/acsnano.4c12036","volume":"19","author":"J Wu","year":"2025","unstructured":"Wu, J. et al. Biomimetic \u201cTrojan Horse\u201d fibers modulate innate immunity cascades for nerve regeneration. ACS Nano 19, 781\u2013802 (2025).","journal-title":"ACS Nano"},{"key":"2598_CR97","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1189\/jlb.0703340","volume":"75","author":"R Boxio","year":"2004","unstructured":"Boxio, R. et al. Mouse bone marrow contains large numbers of functionally competent neutrophils. J. Leukocyte Biol. 75, 604\u2013611 (2004).","journal-title":"J. Leukocyte Biol."},{"key":"2598_CR98","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.7150\/thno.19987","volume":"7","author":"M Kong","year":"2017","unstructured":"Kong, M. et. al. Biodegradable hollow mesoporous silica nanoparticles for regulating tumor microenvironment and enhancing antitumor efficiency. Theranostics 7, 3276\u20133292 (2017).","journal-title":"Theranostics"},{"key":"2598_CR99","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.1021\/acs.chemmater.9b00221","volume":"31","author":"K M\u00f6ller","year":"2019","unstructured":"M\u00f6ller, K. & Bein, T. Degradable drug carriers: vanishing mesoporous silica nanoparticles. Chem. Mater. 31, 4364\u20134378 (2019).","journal-title":"Chem. Mater."},{"key":"2598_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00424-8","volume":"8","author":"M Huo","year":"2017","unstructured":"Huo, M. et al. Tumor-selective catalytic nanomedicine by nanocatalyst delivery. Nat. Commun. 8, 357 (2017).","journal-title":"Nat. Commun."},{"key":"2598_CR101","doi-asserted-by":"publisher","first-page":"4561","DOI":"10.1021\/acsnano.4c14445","volume":"19","author":"MM Long","year":"2025","unstructured":"Long, M. M. et al. Prussian blue nanozyme featuring enhanced superoxide dismutase-like activity for myocardial ischemia reperfusion injury treatment. ACS Nano 19, 4561\u20134581 (2025).","journal-title":"ACS Nano"},{"key":"2598_CR102","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41596-018-0001-1","volume":"13","author":"B Jiang","year":"2018","unstructured":"Jiang, B. et al. Standardized assays for determining the catalytic activity and kinetics of peroxidase-like nanozymes. Nat. Protoc. 13, 1506\u20131520 (2018).","journal-title":"Nat. Protoc."},{"key":"2598_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50344-7","volume":"15","author":"KZ Feng","year":"2024","unstructured":"Feng, K. Z. et al. Elucidating the catalytic mechanism of Prussian blue nanozymes with self-increasing catalytic activity. Nat. Commun. 15, 5908 (2024).","journal-title":"Nat. Commun."},{"key":"2598_CR104","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.actbio.2021.01.020","volume":"123","author":"J Gao","year":"2021","unstructured":"Gao, J. et al. Human neutrophil membrane-derived nanovesicles as a drug delivery platform for improved therapy of infectious diseases. Acta Biomater. 123, 354\u2013363 (2021).","journal-title":"Acta Biomater."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02598-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02598-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02598-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T08:03:14Z","timestamp":1773043394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02598-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":104,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2598"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02598-4","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"23 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}